6118 — Austar Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Austar Lifesciences, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	178	220	148	174	168
Net Total Accounts Receivable
Net Total Receivables	517	673	1,001	1,006	1,000
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,089	1,663	1,801	1,574	1,552
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	186	312	434	444	414
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,379	2,045	2,389	2,159	2,084
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	806	1,136	1,360	1,178	1,189
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	861	1,258	1,492	1,386	1,292
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	518	787	897	773	791
Total Liabilities & Shareholders' Equity	1,379	2,045	2,389	2,159	2,084
Total Common Shares Outstanding